|
|
|
speaker |
presentation |
TIME and Location |
|
PD06: Prostate Cancer: Detection & Screening I
|
1:00 pm
207A |
|
Panel: What I do: Penile Prosthesis Revision Surgeries
|
2:10 pm
Marriott Marquis Ballroom Salon 5 |
|
Nelson Bennett, MD
|
IPP: Sexual Function/Dysfunction: Medical, Hormonal and Non-surgical Therapy I
|
3:30 pm
146C |
|
Early Career Investigators Showcase
|
3:31 pm
202A |
|
014IC - Male Infertility Update 2026: A Comprehensive Approach to Understanding and Treating Male Infertility in the Era of IVF
|
4:00 pm
150AB |
|
Hiten Patel, MD
|
Prostate MRI Utilization and Risk Calculators to Improve the Quality of Prostate Cancer Detection
|
4:33 pm
202A |
|
IP35-02: Real-world outcomes of BCG-retreatment after BCG failure in patients with papillary only high-risk non-muscle-invasive bladder cancer: a Retrospective Study in the American Urological Associations Quality Registry
|
9:30 am
147A |
|
Robotics Theater: Prostate
|
9:30 am
S&T Hall, Booth #117 |
|
Robotics Theater: Reconstruction
|
1:00 pm
S&T Hall, Booth #117 |
|
Nelson Bennett, MD
|
032IC - Andrology, Infertility, and Male Sexual Medicine and Surgery for the General Urologist
|
1:30 pm
152B |
|
Surgery as a Team Sport: Challenges and Solutions
|
3:25 pm
Marriott Marquis: Independence Ballroom Salon B |
|
Hiten Patel, MD
|
IP44: Prostate Cancer: Epidemiology & Natural History
|
3:30 pm
146A |
|
New Wave of Tech Startups for At-Home Sperm Testing
|
4:20 pm
Salon B |
|
Robert Brannigan, MD
|
IP52: Infertility: Epidemiology & Evaluation II
|
7:00 am
146C |
|
Hiten Patel, MD
|
IP53-13: Image Based Phenotyping for PIRADS in VHA Clinical Notes and Radiology Reports
|
7:00 am
174A |
|
Joshua Meeks, MD, PhD
|
A phase 1/2 study of intravesical MK-3120 in participants with Bacillus Calmette-Gue9rin (BCG)-Naive or BCG-exposed high-risk nonmuscle invasive bladder cancer
|
10:04 am
Hall B, The Square, Learning Lab |
|
PD20-10: SaFE-NC Collaborative Redesign of Newborn Circumcision Care Delivery
|
10:42 am
207A |
|
Joshua Meeks, MD, PhD
|
The phase 1/2 ResQ133A-NMIBC trial: A study of intravesical recombinant Mycobacterium Bacillus Calmette Guerin (rBCG) in BCG naive participants with non-muscle invasive bladder cancer (NMIBC)
|
10:44 am
Hall B, The Square, Learning Lab |
|
IP77: Bladder Cancer: Basic Research & Pathophysiology II
|
7:00 am
147A |
|
Plenary: Monday Morning
|
7:20 am
Hall D |
|
Joshua Meeks, MD, PhD
|
PD25-04: A Real-World Evidence Study Assessing the Prevalence and Prognostic Value of FGFR Alterations in Patients With Intermediate Risk NonMuscle-Invasive Bladder Cancer
|
7:24 am
206 |
|
William Catalona, MD
|
056IC - Prostate Cancer Update 2026
|
7:30 am
150AB |
|
059IC - Laser Enucleation of the Prostate: Beyond the Basics
|
7:30 am
152A |
|
Northwestern Medicine Urology is committed to providing personalized, integrative and innovative urologic care and conducting leading-edge research to prevent, diagnose and treat urologic conditions.
The Urology Program at Northwestern Memorial Hospital is among the top 10 programs in the nation and is the highest-ranked in Illinois for the 28th year in a row by U.S. News & World Report, 2025 – 2026. |
|
About Us Terms of Use Privacy Policy How to Vote for U.S. News & World Report Best Hospitals
© 2026 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |